Evolutions in the Management of Duchenne Muscular Dystrophy (DMD): Treatment Implications for the Present and Future
Released On
July 15, 2024
Expires On
April 3, 2025
Media Type
Internet
Completion Time
60 minutes
Specialty
Genetics, Neurology, Pediatrics, Physiatry
Topics
Neuromuscular conditions
This activity is supported by an independent educational grant from Sarepta Therapeutics.
Credit Available
- Physicians - maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses - 1.0 Contact Hours
- Pharmacists — 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit
- Physicians Assistants - maximum of 1.0 AAPA Category 1 CME credits
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This educational activity is intended for healthcare professionals involved in the management of patients with Duchenne Muscular Dystrophy (DMD), including neurologists, neuromuscular specialists, and other members of the healthcare team who care for patients with DMD.
Program Overview
Duchenne muscular dystrophy (DMD) impacts 1 in every 3,500 male births globally, and its progression is both relentless and fatal. However, the rapid advancement in DMD therapies brings hope and substantial progress for those battling this devastating condition. Selecting the optimal treatment regimen for each patient at the right time demands meticulous evaluation. This activity empowers clinicians managing DMD patients to navigate and comprehend the evolving landscape of clinical trial data across diverse treatment modalities, ensuring the best possible care.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the role of dystrophin disruption and restoration in the progression and management of DMD
- Assess the latest clinical trial results across various treatment modalities for DMD
- Examine emerging approaches to DMD management that seek to align patient selection, treatment choice, and optimal initiation of therapy
Faculty
Craig McDonald, MD
Chair, Department of Physical Medicine & Rehabilitation
Professor, Department of Pediatrics and PM&R
UC Davis Health-Sacramento
Sacramento, CA
[email protected]
Crystal Proud, MD
Pediatric Neurologist
Children’s Hospital of The King’s Daughters
Norfolk, VA
[email protected]
Aravindhan Veerapandiyan, MD
Associate Professor
University of Arkansas for Medical Sciences
Arkansas Children’s Hospital
Little Rock, AR
[email protected]
Accreditation Statement
This activity is provided by The France Foundation.
Accreditation Statement
In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The France Foundation designates this activity for 1.0 contact hours.
Physician Assistants
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until April 3, 2025. PAs should only claim credit commensurate with the extent of their participation.
Pharmacists
This knowledge-based activity, UAN JA0007204-0000-24-051-H01-P, qualifies for 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service ([email protected]).
All other healthcare professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts Of Interest
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pretest, completing the activity, and completing the posttest and evaluation form. A score of at least 67% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.
Credit Fulfillment
- If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation, your certificate will be available for download
- If you are a pharmacist requesting ACPE credits, your credits request will be uploaded to CPE Monitor within 60 days
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling.
This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
Disclaimer
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.
COPYRIGHT INFORMATION
Copyright © 2024 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:- The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright altered
- Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except when such information is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
Additional information regarding The France Foundation’s Privacy Policy can be viewed at http://www.francefoundation.com/privacy.
Contact Information
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or [email protected].